AESOP TECHNOLOGY
  • DxPro
    • 好完診
    • 好彙編
  • 用藥領航員
    • 癌症用藥領航員
    • 更多治療應用
  • 藥御守
  • 研究
  • 醫守欲言
  • 最新消息
  • 關於醫守
  • English

Aesop Technology launches CDI tool to help avoid patient record errors

6/5/2022

 
Picture
Adam Ang
Picture
Photo by: Helen King/Getty Images

​California-based medical AI startup Aesop Technology, which has an R&D office in Taiwan, has recently unveiled its latest clinical documentation improvement tool that helps coders spot incorrectly coded diagnoses or procedures.

DxPrime provides suggestions to support medical data entry. The CDI tool is based on a machine learning model that has been trained based on a data set of some 3.2 billion patient visits. According to Aesop Technology, their latest solution for medical coding harnesses AI to "efficiently compensate for traditional CDSS and NLP weaknesses to find correct or missed diagnoses".

WHY IT MATTERS

Now available on digital health marketplace Olive Library, DxPrime provides information on missing and wrongly coded diagnoses or procedures to easily correct patients' charts. 

With incorrect patient records, Aesop claims, patients could be given improper discharge instructions, thus receiving poor after-discharge care. For providers, this could lead to a wrong estimate of their patients' length of stay and wrong code insurance claims, which could ultimately result in denials and revenue losses.

Aesop emphasized that errors in diagnosis input are difficult for physicians to avoid due to the gap in their knowledge of coding systems. Currently, the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10) has 14,400 diseases included in its base classification, 68,000 diagnosis codes under ICD-10-CM and 87,000 procedural codes under ICD-10-PCS.
​THE LARGER TREND

Last month, Aesop's medication decision support tool RxPrime was launched on Olive Helps, a desktop platform for healthcare IT developers. The solution analyses inpatient data using patterns from prescriptions and flags potentially inappropriate prescriptions that do not match a patient's diagnosis. 

In other news, Aesop partnered with Taipei Medical University, Harvard Medical School and Brigham and Women's Hospital last year for a study that ran its machine learning model in EHR systems in the United States. It was found that the model, which provides adaptive suggestions to help doctors better complete their prescriptions, had demonstrated good international transferability.

ON THE RECORD

Jim Long, CEO of Aesop, said: "Physicians, CDI team, and coders have to spend a lot of time poring through medical records to find the key clinical diagnoses among the vast amount of information available. After that, they have to follow a series of inefficient steps on the computer to complete the input process, and search functionality for ICD codes often is not helpful. The whole process is complex, time-consuming, and error-prone".

When using DxPrime, he claimed, doctors were able to notice incorrect code complications. "By assisting them in inputting the proper diagnoses, our partners have seen an increase in revenue of 5-10% per inpatient," Long said.

Reference: MobiHealthNews​

評論已關閉。
    Picture

     

    全部
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    2025
    #AODP
    #BENZINGA
    #COMPUTEX Taipei
    #DIGITIMES
    #EE Times Asia
    #FOCUS TAIWAN
    #HLTH
    #MayoClinicPlatformAccelerate
    Meet創業小聚
    #Mobi Health News
    #Olive Hack For Health
    #PharmStars
    #PR Newswire
    #Taiwan Business TOPICS
    #Taiwan Research Highlight
    #TechNews科技新報
    #Yahoo Finance
    #Yahoo News
    #三立新聞網
    #中時新聞網
    #中時電子報
    #中研院
    #今周刊
    #台灣新生報
    #大紀元
    #天下雜誌
    #寰宇新聞
    #數位時代
    #新創事業獎
    #新創共採供應
    #潛力新創獎
    #環球生技月刊
    #經濟日報
    #臺北生技獎
    #臺北生技獎
    #非凡新聞台
    #飛碟聯播網

醫守科技股份有限公司
AESOP TECHNOLOGY

[email protected]
​Privacy Policy
 ⏤ 防詐騙聲明 ⏤
​近期有網站冒用本公司名稱及相關資訊以誤導大眾。醫守科技特此聲明,本公司及官方網站與任何未經授權之網站或實體均無任何關聯。
​在您分享任何資訊前,請務必確認您所造訪的是本公司之官方網域(www.aesoptek.com及www.aesoptek.tw),以免受騙。
​© AESOP Technology 2025
  • DxPro
    • 好完診
    • 好彙編
  • 用藥領航員
    • 癌症用藥領航員
    • 更多治療應用
  • 藥御守
  • 研究
  • 醫守欲言
  • 最新消息
  • 關於醫守
  • English